Emerging Tim-3 functions in antimicrobial and tumor immunity
- PMID: 21697013
- PMCID: PMC3164311
- DOI: 10.1016/j.it.2011.05.003
Emerging Tim-3 functions in antimicrobial and tumor immunity
Abstract
T cell immunoglobulin-3 (Tim-3) has been identified as a marker of differentiated interferon-γ-producing CD4(+) T helper type 1 and CD8(+) T cytotoxic type 1 cells. The interaction of Tim-3 with its ligand, galectin-9 (Gal-9), induces cell death, and in vivo blockade of this interaction results in exacerbated autoimmunity and abrogation of tolerance in experimental models, establishing Tim-3 as a negative regulatory molecule. Recent studies have uncovered additional mechanisms by which Tim-3 negatively regulates T cell responses, such as promoting the development of CD8(+) T cell exhaustion and inducing expansion of myeloid-derived suppressor cells. In contrast to this inhibitory effect on T cells, Tim-3-Gal-9 interaction promotes macrophage clearance of intracellular pathogens. Here, we focus on the emerging role for Tim-3 in tumor and antimicrobial immunity.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures

Similar articles
-
T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis.Expert Opin Ther Targets. 2012 Dec;16(12):1145-9. doi: 10.1517/14728222.2012.726616. Epub 2012 Sep 22. Expert Opin Ther Targets. 2012. PMID: 22998573 Review.
-
TIM-3 in autoimmunity.Curr Opin Immunol. 2006 Dec;18(6):665-9. doi: 10.1016/j.coi.2006.09.009. Epub 2006 Oct 2. Curr Opin Immunol. 2006. PMID: 17011764 Review.
-
The role of T cell immunoglobulin and mucin domain-3 in immune thrombocytopenia.Scand J Immunol. 2014 Apr;79(4):231-6. doi: 10.1111/sji.12153. Scand J Immunol. 2014. PMID: 24383985 Review.
-
Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31. J Hepatol. 2015. PMID: 25450716 Free PMC article.
-
Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.J Immunol. 2008 Dec 1;181(11):7660-9. doi: 10.4049/jimmunol.181.11.7660. J Immunol. 2008. PMID: 19017954 Free PMC article.
Cited by
-
TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.PLoS One. 2012;7(2):e30676. doi: 10.1371/journal.pone.0030676. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363469 Free PMC article.
-
Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.J Virol. 2015 Apr;89(8):4405-20. doi: 10.1128/JVI.03275-14. Epub 2015 Feb 4. J Virol. 2015. PMID: 25653440 Free PMC article.
-
Tr1-Like T Cells - An Enigmatic Regulatory T Cell Lineage.Front Immunol. 2016 Sep 14;7:355. doi: 10.3389/fimmu.2016.00355. eCollection 2016. Front Immunol. 2016. PMID: 27683580 Free PMC article.
-
Diversity of immune checkpoints in cancer immunotherapy.Front Immunol. 2023 Mar 7;14:1121285. doi: 10.3389/fimmu.2023.1121285. eCollection 2023. Front Immunol. 2023. PMID: 36960057 Free PMC article. Review.
-
Stimulation of Camel Polyclonal Antibody against Human T cell Immunoglobulin and Mucin 3.Iran J Biotechnol. 2017 Sep 27;15(3):166-171. doi: 10.15171/ijb.1427. eCollection 2017. Iran J Biotechnol. 2017. PMID: 29845065 Free PMC article.
References
-
- Monney L, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415(6871):536–541. - PubMed
-
- Asakura H, et al. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol. 2002;169(10):5912–5918. - PubMed
-
- Zhu C, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6(12):1245–1252. - PubMed
-
- Cao E, et al. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity. 2007;26(3):311–321. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS045937-02/NS/NINDS NIH HHS/United States
- P01 AI056299-07/AI/NIAID NIH HHS/United States
- R01 NS045937-06/NS/NINDS NIH HHS/United States
- R01 AI085669-02/AI/NIAID NIH HHS/United States
- R01 NS045937-09/NS/NINDS NIH HHS/United States
- R01 NS045937/NS/NINDS NIH HHS/United States
- P01 AI073748-02/AI/NIAID NIH HHS/United States
- R01 NS045937-05/NS/NINDS NIH HHS/United States
- P01 AI073748-01A1/AI/NIAID NIH HHS/United States
- P01 AI039671/AI/NIAID NIH HHS/United States
- P01 AI056299-06A1/AI/NIAID NIH HHS/United States
- R01 NS045937-04/NS/NINDS NIH HHS/United States
- P01 AI073748/AI/NIAID NIH HHS/United States
- P30 AI060354/AI/NIAID NIH HHS/United States
- R01 AI085669-01A1/AI/NIAID NIH HHS/United States
- P01 AI073748-03/AI/NIAID NIH HHS/United States
- R01 NS045937-07/NS/NINDS NIH HHS/United States
- P01 AI056299/AI/NIAID NIH HHS/United States
- P01 AI039671-15/AI/NIAID NIH HHS/United States
- P01 AI056299-08/AI/NIAID NIH HHS/United States
- R01 NS045937-03/NS/NINDS NIH HHS/United States
- R01 AI085669/AI/NIAID NIH HHS/United States
- P01 AI039671-16/AI/NIAID NIH HHS/United States
- R01 NS045937-01/NS/NINDS NIH HHS/United States
- R01 NS045937-08/NS/NINDS NIH HHS/United States
- P01 AI039671-17/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials